IndraLab

Statements

USP22 inhibits CD3. 1 / 1

| 1

reach

"Flow analysis of the implanted tumors showed that loss of tumor cell-intrinsic USP22 decreased the abundance of gMDSCs and increased the number of CD3 + and CD4 + T cells in the TME of both 6422c1 and 6694c2 tumors (XREF_SUPPLEMENTARY - XREF_SUPPLEMENTARY)."

31871120

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP22 inhibits CD3. 1 / 1

INDRA sources:

Databases

Reading